This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bonventre, P. F. Articles by Imhoff, J. G. Search for Related Content PubMed PubMed Citation Articles by Bonventre, P. F. Articles by Imhoff, J. G.

 Previous Article  |  Next Article 

Infect Immun. 1970 July; 2(1): 89-95
Copyright © 1970 American Society for Microbiology. All Rights Reserved.

Uptake of ³H-Dihydrostreptomycin by Macrophages in Culture

^a Department of Microbiology, University of Cincinnati, College of Medicine, Cincinnati, Ohio 45219
Lister Institute of Preventive Medicine, London, England

ABSTRACT

Mouse peritoneal macrophages, in culture, concentrate significant amounts of ³H-dihydrostreptomycin, provided that the incubation period is sufficiently extended. Macrophages cultured in vitro from both stimulated and unstimulated animals concentrate the antibiotic from growth or maintenance media. The increase in cell-associated radioactivity is linear for almost a week before a plateau is reached. Calculations based on intracellular volumes of the cells indicate that the intracellular concentration of dihydrostreptomycin may attain levels greater than five times that of the external milieu. No uptake is measurable at 4 C, suggesting an active mechanism of transport into the cell. Phagocytosis of killed bacteria during incubation did not increase uptake of the antibiotic nor did the addition of poly-L-ornithine to the medium augment uptake. A nonphagocytic cell line (BHK-21) concentrated ³H-dihydrostreptomycin to a lesser extent than the macrophages. These observations suggest that a wide variety of mammalian cells may be permeable to the antibiotic, and thus potential bactericidal action on intracellular bacteria cannot be ignored.

¹ Most of the investigation was carried out at the Lister Institute of Preventive Medicine, London, England, where P.F.B. was a visiting scientist.

This article has been cited by other articles:

• Maurin, M., Raoult, D. (2001). Use of Aminoglycosides in Treatment of Infections Due to Intracellular Bacteria. Antimicrob. Agents Chemother. 45: 2977-2986 [Full Text]